Anti‐tumour necrosis factor‐associated cutaneous leishmaniasis: a single‐institution experience-Reference-Cited by-同舟云学术

Anti‐tumour necrosis factor‐associated cutaneous leishmaniasis: a single‐institution experience

Published:2019-05-06 Issue:2 Volume:181 Page:403-405
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Martínez‐Doménech A.¹^ORCID,García‐Legaz‐Martínez M.¹^ORCID,Magdaleno‐Tapial J.¹^ORCID,Torrecillas M.²,Hernández‐Bel P.¹,Ocete Mochón M.D.²,Pérez‐Ferriols A.¹,Miquel V. Alegre¹

Affiliation:

1. Department of Dermatology Hospital General Universitario de Valencia Avenida Tres Cruces 2 46014 Valencia Spain

2. Department of Microbiology Hospital General Universitario de Valencia Avenida Tres Cruces 2 46014 Valencia Spain

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17644

Reference8 articles.

1. Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management

2. Case Report: Diffuse Cutaneous Leishmaniasis by Leishmania infantum in a Patient Undergoing Immunosuppressive Therapy: Risk Status in an Endemic Mediterranean Area

3. Cutaneous leishmaniasis associated with anti-tumour necrosis factor-α drugs: an emerging disease

4. Anti-Tumour Necrosis Factor-Induced Visceral and Cutaneous Leishmaniasis: Case Report and Review of the Literature

5. Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leishmania infantum infection after visiting southern Spain in patients on biological treatment; an observational, longitudinal, cohort study;Travel Medicine and Infectious Disease;2023-05

2. Klinisch‐pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF‐α‐Inhibitoren behandelten Patienten;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-05

3. Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF‐α inhibitors;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-04-12

4. Leishmaniasis y fármacos anti-TNF;Piel;2021-11

5. Erythematous plaques with zosteriform distribution in a patient treated with TNF‐α inhibitor adalimumab for psoriasis;International Journal of Dermatology;2021-06-17